We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Central Garden & Pet Co
CENT
$2.78B
| $5.38M | 0.04% |
249,435
-111,853
| -31% | -$2.47M |
|
|
TYPE
452
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $5.38M | 0.04% |
319,302
+303,910
| +1,974% | +$5.41M |
|
453
Deere & Co
DE
$173B
| $5.38M | 0.04% |
+32,435
| New | +$5.05M |
|
|
FPAC.U
454
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $5.37M | 0.04% |
503,700
| – | – |
|
|
NEBUU
455
DELISTED
Nebula Acquisition Corporation Unit
NEBUU
| $5.35M | 0.04% |
500,000
| – | – |
|
456
Caterpillar
CAT
$387B
| $5.33M | 0.04% |
39,071
-61,164
| -61% | -$8.08M |
|
|
PSDO
457
DELISTED
Presidio, Inc. Common Stock
PSDO
| $5.32M | 0.04% |
389,258
-210,119
| -35% | -$2.96M |
|
458
Cisco
CSCO
$456B
| $5.32M | 0.04% |
+97,133
| New | +$5.36M |
|
459
Oneok
OKE
$55.9B
| $5.32M | 0.04% |
+77,242
| New | +$5.21M |
|
|
AXON
460
Axon Enterprise
AXON
$44.1B
| $5.31M | 0.04% |
82,756
+708
| +0.9% | +$46.2K |
|
461
Take-Two Interactive
TTWO
$46B
| $5.31M | 0.04% |
46,789
-62,822
| -57% | -$6.47M |
|
|
DFBHU
462
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $5.31M | 0.04% |
500,000
| – | – |
|
|
NATI
463
DELISTED
National Instruments Corp
NATI
| $5.31M | 0.04% |
126,385
+31,180
| +33% | +$1.33M |
|
464
Intuitive Surgical
ISRG
$130B
| $5.3M | 0.04% |
30,309
-50,958
| -63% | -$8.73M |
|
465
Amphenol
APH
$177B
| $5.29M | 0.04% |
220,332
+220,204
| +172,034% | +$5.3M |
|
|
ESGR
466
DELISTED
Enstar Group
ESGR
| $5.26M | 0.04% |
30,207
+25,958
| +611% | +$4.5M |
|
467
Fomento Económico Mexicano
FMX
$43.5B
| $5.22M | 0.04% |
53,989
+53,598
| +13,708% | +$5.19M |
|
|
VBTX
468
DELISTED
Veritex Holdings
VBTX
| $5.16M | 0.04% |
198,859
-230,655
| -54% | -$5.98M |
|
|
FLG
469
Flagstar Bank National Association
FLG
$5.83B
| $5.14M | 0.04% |
+171,687
| New | +$5.54M |
|
470
Jefferies Financial Group
JEF
$13.2B
| $5.13M | 0.04% |
297,951
-12,042
| -4% | -$207K |
|
471
Dover
DOV
$27.4B
| $5.13M | 0.04% |
51,163
-95,366
| -65% | -$9.15M |
|
472
Tyson Foods
TSN
$21.5B
| $5.11M | 0.04% |
+63,334
| New | +$4.88M |
|
473
Franco-Nevada
FNV
$40.6B
| $5.07M | 0.04% |
59,600
+59,200
| +14,800% | +$4.47M |
|
|
SYKE
474
DELISTED
SYKES Enterprises Inc
SYKE
| $5.06M | 0.04% |
+184,421
| New | +$4.96M |
|
|
TRTX
475
TPG RE Finance Trust
TRTX
$660M
| $5.03M | 0.04% |
260,650
-416,497
| -62% | -$8.16M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.